January 23, 2008

Back to all media releases

Sandoz Annual Conference 2008
 

Cox's Bazar - Chittagong, January 23, 2008 - All Associates from the Sandoz Division of Novartis (Bangladesh) limited attended the Sandoz Annual Conference 2008 at Cox's Bazar.

The conference started with a reflection on the previous year's performance and highlighted the above market growth contrary to the industry trend or negative growth. Various strategies and programs were discussed that highlighted the events and business direction in 2008. At the end of the conference 59 Associates from the division were rewarded for their exemplary performances in 2007.

Novartis is a world leader in offering medicines to protect health, treat diseases and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. Novartis is the only company with leadership positions in both patented and generic pharmaceuticals (Sandoz). We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high quality and affordable generics (Sandoz), human vaccines and leading self-medication OTC brands. Headquartered in Basel, Switzerland, Novartis Group companies employ more than 100,000 people and operate in over 140 countries around the world.

Novartis has manufacturing and marketing operations in Bangladesh since 1973 in areas of Research, Off Patent Branded Generic (Sandoz) and OTC Pharmaceuticals along with Animal Health.

###

Rasna Hasan

Head of Corporate Affairs and Communication

Novartis (Bangladesh) limited

House 50, Road 2A

Dhanmondi RA

Dhaka 1209

BANGLADESH

+880 2 8615302-8

 rasna.hasan@sandoz.com

The information in the media releases on these pages was factually accurate on the date of publication. These media releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

Lucentis

Aclasta

Sebivo

Doloran PRT